Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia

被引：41

作者：

Richards, Michael ^{[1
]}

Knox, James ^{[2
,3
]}

Elliott, Briony ^{[4
]}

Mackin, Kate ^{[5
]}

Lyras, Dena ^{[5
]}

Waring, Lynette J. ^{[3
]}

Riley, Thomas V. ^{[4
,6
]}

机构：

[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[2] Monash Med Ctr, Dept Infect Dis, Melbourne, Vic, Australia

[3] Melbourne Pathol, Melbourne, Vic, Australia

[4] Univ Western Australia, Perth, WA 6009, Australia

[5] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia

[6] PathWest Lab Med, Perth, WA, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2011年 / 194卷 / 07期

关键词：

EPIDEMIC; DIARRHEA; COLITIS; METRONIDAZOLE; VANCOMYCIN; DIAGNOSIS; AMERICA; DISEASE; STRAIN;

D O I：

10.5694/j.1326-5377.2011.tb03012.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report the first recognised case of infection with Clostridium difficile PCR ribotype 027 acquired in Australia. This pathogen has caused significant morbidity and mortality in widespread hospital-based outbreaks in the northern hemisphere. Clinicians need to be aware of the clinical picture, limitations of diagnostic tests, availability of further testing for epidemic strains, new therapeutic approaches, and in-hospital control strategies for this infection. (MJA 2011; 194: 369-371)

引用

页码：369 / 371

页数：3

共 19 条

[11] Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile
ONeill, GL
Ogunsola, FT
Brazier, JS
Duerden, BI
[J]. ANAEROBE, 1996, 2 (04) : 205 - 209
[12] Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
Pépin, J
Saheb, N
Coulombe, MA
Alary, ME
Corriveau, MP
Authier, S
Leblanc, M
Rivard, G
Bettez, M
Primeau, V
Nguyen, M
Jacob, CE
Lanthier, L
[J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) : 1254 - 1260
[13] Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
Planche, Tim
Aghaizu, Adamma
Holliman, Richard
Riley, Peter
Poloniecki, Jan
Breathnach, Aodhan
Krishna, Sanjeev
[J]. LANCET INFECTIOUS DISEASES, 2008, 8 (12) : 777 - 784
[14] First Australian isolation of epidemic Clostridium difficile PCR ribotype 027
Riley, Thomas V.
Thean, Sarah
Hool, Graham
Golledge, Clayton L.
[J]. MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (12) : 706 - 708
[15] STUART RL, 2011, HEALTHCARE IN PRESS
[16] Clostridium difficile-associated diarrhea:: Epidemiological data from Western Australia associated with a modified antibiotic policy
Thomas, C
Stevenson, M
Williamson, DJ
Riley, TV
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (12) : 1457 - 1462
[17] Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
Warny, M
Pepin, J
Fang, A
Killgore, G
Thompson, A
Brazier, J
Frost, E
McDonald, LC
[J]. LANCET, 2005, 366 (9491) : 1079 - 1084
[18] What Is the Current Role of Algorithmic Approaches for Diagnosis of Clostridium difficile Infection?
Wilcox, Mark H.
Planche, Tim
Fang, Ferric C.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (12) : 4347 - 4353
[19] A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Zar, Fred A.
Bakkanagari, Srinivasa R.
Moorthi, K. M. L. S. T.
Davis, Melinda B.
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (03) : 302 - 307

← 1 2 →